Ubs Asset Management Americas Inc Kronos Bio, Inc. Transaction History

Ubs Asset Management Americas Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$18.17 - $24.7 $62,813 - $85,387	-3,457 Reduced 2.36%	142,749 $2.99 Million
Q2 2021 Aug 16, 2021	SELL	$20.08 - $29.02 $108,994 - $157,520	-5,428 Reduced 3.58%	146,206 $3.5 Million
Q1 2021 May 14, 2021	BUY	$27.0 - $32.48 $4.09 Million - $4.93 Million	151,634 New	151,634 $4.44 Million

20.7M

31.4K

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $55.1M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.